CNMD vs SIBN
CNMD: CONMED is a global medical technology company specializing in innovative surgical devices and equipment for minimally invasive procedures. SIBN: SI-BONE is a medical device company providing minimally invasive surgical solutions to treat conditions of the sacroiliac joint and spinopelvic anatomy.
Side-by-side fundamentals
| Metric | CNMD | SIBN | Edge |
|---|---|---|---|
| Price as of 2026-08-06 close | $49.77 | $18.14 | |
| Market cap as of 2026-08-08 | $1.5B | $813M | |
| P/E as of 2026-08-08 | 26.15 | n/a | |
| Net margin as of 2026-08-08 | +4.1% | -8.1% | CNMD higher |
| Gross margin as of 2026-08-08 | +55.8% | +79.6% | SIBN higher |
| Operating margin as of 2026-08-08 | +8.0% | -9.7% | CNMD higher |
| ROE as of 2026-08-08 | +5.5% | -9.6% | CNMD higher |
| ROA as of 2026-08-08 | +2.4% | -7.1% | CNMD higher |
| Debt / equity as of 2026-08-08 | 0.80 | 0.20 | SIBN lower |
| Revenue growth (YoY) as of 2026-08-08 | +3.4% | +16.8% | SIBN higher |
| Revenue CAGR (3y) SEC XBRL | +9.6% | +23.6% | SIBN higher |
| Dividend yield as of 2026-08-08 | +1.6% | n/a | |
| Dividend streak (yrs) SEC XBRL | 1 | 0 | CNMD higher |
| Beta as of 2026-08-08 | 0.95 | 0.67 | |
| 1-year return as of 2026-08-06 close | -2.5% | +10.5% | SIBN higher |
Fundamentals: market data, as of 2026-08-08. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-06.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.